Background:
Aldosterone dysregulation is becoming more widely acknowledged as a key factor in resistant hypertension. Baxdrostat, a highly selective aldosterone synthase inhibitor that shows a 100:1 preference for CYP11B2 over CYP11B1, has been tested in various randomized controlled trials involving different hyper...
Adir Alper, M. Lerner, A. Karthikeyan et al.· Circulation· 0 citations
Background:
The optimal strategy for long-term oral anticoagulation (OAC) after catheter ablation for atrial fibrillation (AF) remains uncertain. Although current guidelines recommend anticoagulation based on thromboembolic risk scores irrespective of rhythm status, this recommendation has not been validated by rand...
A. Karthikeyan, Maisha Maliha, Adir Alper et al.· Circulation· 0 citations
Background:
Elevated lipoprotein(a) [Lp(a)] is a heritable, independent risk factor for atherosclerotic cardiovascular disease, and it is not meaningfully reduced by statins or ezetimibe. Whether elevated Lp(a) translates into measurable residual cardiovascular and limb ischemic risk in patients who have achieved an...
Maryam Mojarrad Sani, A. Nouri, Ashkan Abdollahi et al.· Circulation· 0 citations
BACKGROUND
Fractional flow reserve (FFR) and intravascular imaging (IVI) are both used to guide management of intermediate coronary stenoses, but comparative outcome data remain limited.
METHODS
We systematically searched MEDLINE/PubMed and the Cochrane Central Register of Controlled Trials from inception through Sep...
Sharanya Kaushik, A. M. Balakrishna, Shreya Arvind et al.· Current problems in cardiolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.